A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection. [electronic resource]
Producer: 20020926Description: CR257-62 p. digitalISSN:- 1234-1010
- Abdominal Pain -- chemically induced
- Adult
- Aged
- Alanine Transaminase -- blood
- Angina Pectoris -- complications
- Antiviral Agents -- adverse effects
- Biomarkers
- Bronchopneumonia -- chemically induced
- Colitis, Ulcerative -- chemically induced
- DNA, Viral -- blood
- Female
- Gastrointestinal Diseases -- chemically induced
- Hepatitis B Antibodies -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- adverse effects
- Male
- Middle Aged
- Poland
- Reverse Transcriptase Inhibitors -- adverse effects
- Safety
- Urinary Tract Infections -- chemically induced
- Viral Load
- Viremia -- drug therapy
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.